← Back to Search

MHRC camera for Alzheimer's Disease

N/A

Waitlist Available

Led By Sandra Black, MD

Research Sponsored by Optina Diagnostics Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 21 days following clinical characterization completion

Awards & highlights

Study Summary

This trial is testing a new camera that takes pictures of the retina in different colors to see if it can detect Alzheimer's disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 21 days following clinical characterization completion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 21 days following clinical characterization completion

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 21 days following clinical characterization completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Retinal beta-amyloid detection

Trial Design

1Treatment groups

Experimental Treatment

Group I: MHRC cameraExperimental Treatment1 Intervention

Subjects will undergo a retina imaging session with the MHRC camera.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MHRC

2017

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreOTHER

655 Previous Clinical Trials

1,550,197 Total Patients Enrolled

Optina Diagnostics Inc.Lead Sponsor

8 Previous Clinical Trials

5,098 Total Patients Enrolled

McGill UniversityOTHER

392 Previous Clinical Trials

984,458 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Recent research and studies

clinicaltrials.govStudy

Retinal Metabolic Imaging of Alzheimer Patient

2017. "Retinal Metabolic Imaging of Alzheimer Patient". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03420807.

~7 spots leftby Apr 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.